High-field iMRI in glioblastoma surgery: improvement of resection radicality and survival for the patient?

Acta neurochirurgica. Supplement

Volumn 109, Issue , 2011, Pages 103-106

  Mehdorn, H Maximilian ^a   Schwartz, Felix ^b   Dawirs, Stefan ^b   Hedderich, Jürgen ^b   Dörner, Lutz ^b   Nabavi, Arya ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE;

ARTICLE; BRAIN TUMOR; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; INSTRUMENTATION; KARNOFSKY PERFORMANCE STATUS; MALE; METHODOLOGY; MORTALITY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; RETROSPECTIVE STUDY;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; DACARBAZINE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MAGNETIC RESONANCE IMAGING; MALE; MONITORING, INTRAOPERATIVE; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES;

EID: 79952279630     PISSN: 00651419     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-211-99651-5_16     Document Type: Article

References (0)